Wolfe starts AbbVie at Outperform, says valuation an attractive entry point
Wolfe Research initiated coverage of AbbVie (ABBV) with an Outperform rating and $205 price target The firm noted that AbbVie sounded ...
Business Insider1d
AbbVie initiated with an Outperform at Wolfe Research
Wolfe Research initiated coverage of AbbVie (ABBV) with an Outperform rating and $205 price target Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news.